Danfoss logo
TXI injection valve

Desuperheating valve, TXI 2, Flare

068-7449

Inlet size [in]: 3/8 in, Inlet connection type: Flare, Outlet size [in]: 1/2 in, Outlet connection type: Flare, Pressure range (Pi) [bar]: 1 - 5, Temperature range [°C]: 100 - 130
The product is no longer available for purchase, but you can still find information about it, including service manuals, drawing etc.

If you're looking for a similar product, you can check out other options within the same product type by visiting the product type page.: TXI 2

Product specifications

Characteristic
Value
ApprovalEACLLC CDC TYSK
Body materialBrass
Capillary tube length [in]59.0 in
Capillary tube length [mm]1500 mm
China RoHS complianceYes exceed limitations
DG Indicator ProfileOther Dangerous Goods
DirectionAngleway
EU RoHS complianceYes with exemptions
EU RoHS exemption clause6(a)6(c)
Fluid Group2
In scope of WEEE and contain batteriesNo
Inlet connection typeFlare
Inlet size [in]3/8 in
Material DescriptionTXI2 Desuperheat valve w/o Orifice
Max. Working Pressure [bar]34.0 bar
Max. Working Pressure [psig]500 psig
Outlet connection typeFlare
Outlet size [in]1/2 in
Packing formatMulti pack
Characteristic
Value
PED categoryArt. 4, par. 3
Pressure range (Pi) [bar] [max]5 bar
Pressure range (Pi) [bar] [min]1 bar
Product groupExpansion valves
Product lineAir Conditioning and Commercial Refrigeration
Product nameDesuperheating valve
Product TypeTXI 2
Quantity per packing format20 pc
REACH Candidate List substancesLead (CAS no. 7439-92-1)
SCIP dossier no.c164ed45-f10d-4d73-9eae-355ccb479f4b
SCIP dossier product nameT2 /TE2 - Thermostatic Expansion Valve
Static Superheat (SS) [°C]140.00 °C
Static Superheat (SS) [°F]252.00 °F
Temperature range [°C] [max]130 °C
Temperature range [°C] [min]100 °C
Temperature range [°F] [max]265 °F
Temperature range [°F] [min]212 °F
UK RoHS complianceOut of scope

General specifications

Characteristic
Value
Gross weight0.348 Kilogram
Net weight0.313 Kilogram
Volume0.661 Liter
Characteristic
Value
EAN5702422099260
Proposition 65Cancer and Reproductive Harm